Matt Phipps
Stock Analyst at William Blair
(2.54)
# 2,962
Out of 5,053 analysts
624
Total ratings
44.3%
Success rate
0.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matt Phipps
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BMY Bristol-Myers Squibb Company | Reiterated: Hold | n/a | $56.67 | - | 63 | Oct 12, 2026 | |
| GMAB Genmab | Reiterated: Buy | n/a | $36.57 | - | 27 | Oct 5, 2026 | |
| CGEM Cullinan Therapeutics | Reiterated: Buy | n/a | $14.10 | - | 27 | Oct 2, 2026 | |
| JBIO Jade Biosciences | Reiterated: Buy | n/a | $13.42 | - | 7 | Sep 30, 2026 | |
| ABBV AbbVie | Reiterated: Buy | n/a | $274.36 | - | 13 | Sep 28, 2026 | |
| AUTL Autolus Therapeutics | Reiterated: Buy | n/a | $1.62 | - | 44 | Sep 25, 2026 | |
| KYTX Kyverna Therapeutics | Reiterated: Buy | n/a | $5.77 | - | 1 | Sep 24, 2026 | |
| AMGN Amgen | Reiterated: Buy | n/a | $412.84 | - | 43 | Sep 22, 2026 | |
| CMPX Compass Therapeutics | Reiterated: Buy | n/a | $0.857 | - | 9 | Sep 22, 2026 | |
| NAMS NewAmsterdam Pharma Company | Reiterated: Buy | n/a | $20.19 | - | 16 | Sep 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $2.40 | - | 1 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $5.88 | - | 18 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.55 | - | 23 | Sep 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $10.31 | - | 15 | Sep 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $802.64 | - | 15 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.60 | - | 20 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $108.62 | - | 49 | Aug 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $17.18 | - | 20 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.23 | - | 2 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.275 | - | 12 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $96.79 | - | 14 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $23.52 | - | 13 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.24 | - | 9 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $11.23 | - | 11 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.4956 | - | 18 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $156.32 | - | 1 | Jan 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $117 | $42.38 | n/a | 1 | Oct 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $77.58 | n/a | 1 | Sep 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.95 | n/a | 19 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $10.23 | n/a | 8 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $485.22 | n/a | 1 | Jun 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $216.25 | n/a | 1 | Jun 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.05 | n/a | 11 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.6813 | n/a | 5 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $1.2 | $6.89 | n/a | 1 | Mar 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.7546 | n/a | 13 | Dec 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $128.51 | n/a | 19 | Jan 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $9.31 | n/a | 14 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.0001 | n/a | 11 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.9995 | n/a | 1 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $228.90 | n/a | 26 | Jul 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $37.92 | n/a | 1 | Jun 11, 2021 |
Bristol-Myers Squibb Company
Oct 12, 2026
Reiterated: Hold
Price Target: n/a
Current: $56.67
Upside: -
Genmab
Oct 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $36.57
Upside: -
Cullinan Therapeutics
Oct 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $14.10
Upside: -
Jade Biosciences
Sep 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $13.42
Upside: -
AbbVie
Sep 28, 2026
Reiterated: Buy
Price Target: n/a
Current: $274.36
Upside: -
Autolus Therapeutics
Sep 25, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.62
Upside: -
Kyverna Therapeutics
Sep 24, 2026
Reiterated: Buy
Price Target: n/a
Current: $5.77
Upside: -
Amgen
Sep 22, 2026
Reiterated: Buy
Price Target: n/a
Current: $412.84
Upside: -
Compass Therapeutics
Sep 22, 2026
Reiterated: Buy
Price Target: n/a
Current: $0.857
Upside: -
NewAmsterdam Pharma Company
Sep 18, 2026
Reiterated: Buy
Price Target: n/a
Current: $20.19
Upside: -
Sep 15, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $2.40
Upside: -
Sep 9, 2026
Reiterated: Hold
Price Target: n/a
Current: $5.88
Upside: -
Sep 8, 2026
Reiterated: Buy
Price Target: n/a
Current: $3.55
Upside: -
Sep 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $10.31
Upside: -
Sep 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $802.64
Upside: -
Aug 31, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.60
Upside: -
Aug 19, 2026
Reiterated: Hold
Price Target: n/a
Current: $108.62
Upside: -
Aug 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $17.18
Upside: -
Aug 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.23
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $0.275
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $96.79
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $23.52
Upside: -
Aug 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.24
Upside: -
Aug 4, 2026
Reiterated: Hold
Price Target: n/a
Current: $11.23
Upside: -
Jun 1, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.4956
Upside: -
Jan 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $156.32
Upside: -
Oct 11, 2025
Reiterated: Buy
Price Target: $117
Current: $42.38
Upside: n/a
Sep 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $77.58
Upside: n/a
Aug 29, 2025
Rated: Hold
Price Target: n/a
Current: $6.95
Upside: n/a
Aug 29, 2025
Rated: Hold
Price Target: n/a
Current: $10.23
Upside: n/a
Jun 28, 2025
Reiterated: Buy
Price Target: n/a
Current: $485.22
Upside: n/a
Jun 7, 2025
Reiterated: Hold
Price Target: n/a
Current: $216.25
Upside: n/a
Apr 25, 2025
Rated: Hold
Price Target: n/a
Current: $1.05
Upside: n/a
Apr 25, 2025
Rated: Hold
Price Target: n/a
Current: $0.6813
Upside: n/a
Mar 29, 2025
Initiated Coverage: Buy
Price Target: $1.2
Current: $6.89
Upside: n/a
Dec 29, 2022
Rated: Hold
Price Target: n/a
Current: $0.7546
Upside: n/a
Jan 3, 2022
Reiterated: Buy
Price Target: n/a
Current: $128.51
Upside: n/a
Dec 7, 2021
Reiterated: Buy
Price Target: n/a
Current: $9.31
Upside: n/a
Dec 7, 2021
Reiterated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Nov 19, 2021
Reiterated: Buy
Price Target: n/a
Current: $0.9995
Upside: n/a
Jul 23, 2021
Rated: Buy
Price Target: n/a
Current: $228.90
Upside: n/a
Jun 11, 2021
Reiterated: Buy
Price Target: n/a
Current: $37.92
Upside: n/a